Timing of Peak Troponin T and Creatine Kinase-MB Elevations after Percutaneous Coronary Intervention

Chest

Volumn 125, Issue 1, 2004, Pages 275-280

  Miller, Wayne L ^a   Garratt, Kirk N ^a   Burritt, Mary F ^a   Reeder, Guy S ^a   Jaffe, Allan S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biomarkers; Coronary artery disease; Creatine kinase MB; Peak values; Percutaneous coronary intervention; Troponin T

Indexed keywords

ABCIXIMAB; BIOLOGICAL MARKER; CREATINE KINASE MB; ENZYME; TROPONIN T;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 1642534552     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.275     Document Type: Article

References (29)

1. Cantor WJ, Newby LK, Christenson RH, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39:1738-1744
2. Wu AH, Apple FS, Gilber WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45:1104-1121
3. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31:241-251
4. Spadaro JJ, Philip AL, Tiefenbrunn AJ, et al. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cathet Cardiovasc Diagn 1986; 12:230-234
5. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 1999; 33:88-96
6. Simoons ML, van den Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 1999; 20:1112-1119
7. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1529
8. Kong TQ, Davidson CJ, Meyers SN, et al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997; 277:461-466
9. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335:1333-1341
10. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000; 102:1216-1220
11. Morros DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001; 286:2405-2412
12. Apple FS, Wu AHB, Jaffe AS. Guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002; 144:981-986
13. Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CK mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127:13-20
14. Karim MA, Shinn M, Oskarsson H, et al. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995; 76:521-523
15. La Vecchia L, Bedogni F, Finocchi G, et al. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis 1996; 7:535-540
16. Shyu KG, Kuan PL, Cheng JJ, et al. Cardiac troponin T, creatine kinase and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J 1998; 135:862-867
17. Johansen O, Brekke M, Stromme JH, et al. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J 1998; 19:112-117
18. Kleiman NS, Lakkis N, Cannon CP, et al. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST elevation acute coronary syndromes. J Am Coll Cardiol 2002; 40:1044-1050
19. Topol EJ, Moliterno DJ, Herrmann HC, et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revasculization. N Engl J Med 2001; 344: 1888-1894
20. Newby LK, Ohman EM, Christensen RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the PARAGON-B Troponin T Substudy. Circulation 2001; 103:2891-2896
21. Lincoff AM, Tcheng JE, Califf RM, et al. Sustained suppression of ischemic complications of coronary interventions by platelet GP IIb/IIIa blockade with abciximab: one year outcome in the EPILOG trial. Circulation 1999; 99:1951-1958
22. Lincoff AM, Califf RM, Anderson KM, et al. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 FaB) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997; 30:149-156
23. Kugelmass AD, Cohen DJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectoniy and stenting. Am J Cardiol 1994; 74:748-754
24. Abdelmeguid AE, Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatinine kinase elevation after percutaneous coronary interventions. Am Heart J 1996; 131: 1097-1105
25. Thel MC, Califf RM, Tardiff BE, et al. Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT II). Am J Cardiol 2000; 85:427-434
26. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36:959-969
27. Bertinchant JP, Polge A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84:51-57
28. Vatner SF, Baig H, Manders WT, et al. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1978; 61:1048-1056
29. Bonz AW, Lengenfelder B, Strotmann J, et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol 2002; 40:662-668